DOI: http://dx.doi.org/10.18203/2349-3291.ijcp20172668

The effects on carotid artery intima-media wall thickness and development of atherosclerosis in children on anti-epileptic drug monotherapy

Rosina Ksoo, Rakesh Sharma, R. K. Kaushal, Anupam Jhobta

Abstract


Background: Children with seizure disorder and requiring long-term anti-epileptic drugs are predisposed for development of atherosclerosis. We monitored the carotid artery intima wall thickness of the children on Anti-epileptic drug monotherapy along with their lipid profile for a period of one year.

Methods: Children under 18 years, who were newly diagnosed with epilepsy or were already on anti-epileptic drug monotherapy were included in the study period of one year. They were then prospectively followed-up at three months and again between the sixth and twelfth month’s period. A high-resolution B-mode ultrasound using a 5-7 MHz linear transducer was employed for measuring the thickness of the carotid intima-media thickness (cIMT). The biochemical parameters including fasting lipid profile, body mass index and dietary habits were also taken.

Results: A total of 130 children were included in the study. The values of cIMT observed were 0.38 mm (0.1 mm) and 0.41 mm (0.1mm) in the new (control) and old cases respectively. The values of cIMT were significantly increased in patients receiving Carbamazepine (CBZ) and Phenytoin after 3 months of therapy and with increase in age and duration of intake of anti-epileptic drugs. There were no gender differences in the value of cIMT.

Conclusions: The values of serum cholesterol, LDL and HDL were significantly increased in children on CBZ and valproic acid. There was no difference in the lipid profiles of children on Phenytoin and Phenobarbitone. However, the atherogenic indices of the children taking any of the four anti-epileptic drugs were normal. 


Keywords


Anti-epileptic drugs, Atherosclerosis, Carotid IMT, Monotherapy, Seizure

Full Text:

PDF

References


Johnston MV. Seizures in Childhood. In Kliegman R, Behrman R, Jenson H, Stanton B editors. Nelson textbook of pediatrics. Edition 19. WB Saunders; Philadelphia; 1993.

Muuronen A, Kaste M, Nikkila EA. Mortality from ischemic heart disease among the patient using anticonvulsant drugs. BMJ. 1985;291:1481-3.

Tumer L, Serdaroglu A, Hasanoglu A, Biberoglu G, Aksoy E. Plasma homocysteine and lipoprotein (a) levels as risk factors for atherosclerotic vascular disease in epileptic children taking anticonvulsants. Acta Paediatr. 2002;91:923-6.

Strong JP, Zieske AW, Malcom GT. Lipoproteins and atherosclerosis in children: an early marriage?. Nuts Metab Cardiovasc Dis. 2001;11:16-22.

Berenson GS, Srinivasan SR, Bao W, Newman WP, Tracey RE, Wattigney WA. Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults. The Bogalusa Heart Study. N Engl J Med. 1998;338: 1650-6.

Bots ML, Hoes AW, koudstaal PJ, Hofman A, Grobbee DE. Common carotid intima-media thickness and risk of stroke and myocardial infarction: the Rotterdam Study. Circulation. 1997. 96:1432-7.

Ropper AH, Brown RH, Epilepsy and other seizure disorder. In Adam’s and victor’s principle of neurology. Edition 8. WB Mc Graw-Hill, USA. 2005:292-5.

Allain CC, Poon LS, Chan CSG, Richmond W, Fu PC. Enzymatic determination of total serum cholesterol. Clin Chem. 1974;20:470-5.

Gordon T, Castelli WP, Hjortland MC, Kannel WB, Dawber TR. High density lipoprotein as a protective factor against coronary heart disease. Am J Med. 1977;62:707-14.

Schettler G and Nussel E. Method for triglyceride. Aeb Med Soz Med Prav Med. 1975;10:25-9.

Friedewald WT, Levy RT, Fredrickson DS. Estimation of concentratin of low-density lipoprotein cholesterol without the use of preparative centrifuge. Clin Chem. 1989;22:417- 23.

Kumar P, Tyagi M, Tyagi YK, Kumar A, Kumar A, Rai YK. Effect of Anticonvulsant Drugs on Lipid Profile In Epileptic Patients. The Internet J Neurol. 2004;3:1.

Eiris JM, Castro-Gago M, Lojo S. Effect of long term treatment with antiepileptic drugs on serum lipid levels in children with epilepsy. Neurol. 1995; 45:1155-7.

Naithani M, Chopra S, Somani BL, Singh RK. Studies on Adverse metabolic effects of antiepileptics and their correlation with blood components. Current Neurobiol. 2010;1:117-20.

Mahmoudian T, Iranpour R, Messri N. Serum lipid levels during carbamazepine therapy in epileptic children. Epilepsy Behav. 2005;6:257-9.

Yilmaz E, Doşan Y, Gürgöze MK, Gungor S. Serum lipid changes during anticonvulsive treatment, serum lipids in epileptic children. Acta Neurol Belg. 2001;101:217-20.

Franzoni E, Govoni M, D’Addato S. Total Cholesterol, High-density lipoprotein cholesterol, and triglycerides in children receiving antiepileptic drugs. Epilepsia. 1992;33:932- 5.

Eiris J, Novo-Rodriquez MI, Del Rio M, Meseguer P, Castro-Cago M. The effects on lipid and apolipoprotein serum levels of long-term carbamazapine, valproic acid, and Phenobarbital therapy in children with epilepsy. Epilepsy Res. 2000;41:1-7.

Mieczysław L, Trelewicz J, Zbigniew W. Intima media thickness and arterial elasticity in hypertensive children: controlled study. Pediatr Nephrol. 2004;19:767-74.

Zhu W, Huang X, He J, Li M, Neubauer H. Arterial intima-media thickening and endothelial dysfunction in obese Chinese children. Eur J Pediatr. 2005;164:337-44.

Dawson JD, Sonka M, Blecha MB, Lin W, Davis PH. Risk factors associated with aortic and carotid intima-media thickness in adolescents and young adults. J Am Coll Cardiol. 2009;53:2273-79.

Savitha MR, Sandeep B. The study of lipid profile, diet and other cardiovascular risk factors in children born to parents having premature ischemic heart disease. Indian J Community Med. 2011;36:291-5.

Webber LS, Srinivasan SR, Wattigney WA, Berenson GS. Tracking of serum lipids and lipoproteins from childhood to adulthood: The Bogalusa Heart Study. Am J Epidemiol. 1991;133:884-99.

Chuang YC, Chuang YH, Lin TK, Lu CH, Chang WN, Chen SD et al. Effects of long term anti-epileptic drug monotherapy on vascular risk factors and atherosclerosis. Epilepsia. 2012;53:120-8.

Kantoush MM, El-Shahawy AK, Sokker SS, Serag HR. Effects of treatment with antiepileptic drugs on serum lipid profile in epileptic children. Alex. J Pediatr. 1998;12:153-8.

Verrotti A, Di Marco G, La torre R, Pellicia P, Chiarelli F. Non-alcoholic liver disease during Valproate therapy. European J Pediatr. 2009;168: 1391-4.

Tekgul H, Demir N, Gokben S. Serum lipid profile in children receiving antiepileptic drug monotherapy: is it atherogenic?. J Pediatr Endocrinol Metab. 2006;19:1151-5.